The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Nivolumab with chemotherapy as neoadjuvant treatment for inflammatory breast cancer.
 
Maryann J. Kwa
Research Funding - Bristol-Myers Squibb (Inst)
 
Yelena Novik
No Relationships to Disclose
 
James L. Speyer
No Relationships to Disclose
 
Matija Snuderl
Leadership - C2i genomics; Pandemic Response Lab
Stock and Other Ownership Interests - C2i genomics
Honoraria - Illumina
Consulting or Advisory Role - C2i genomics
Research Funding - Lilly
Travel, Accommodations, Expenses - Illumina; Silicon Biosytems
 
Paolo Cotzia
No Relationships to Disclose
 
Kathy Miller
Consulting or Advisory Role - AstraZeneca; Athenex; Bristol-Myers Squibb/Celgene; Genentech/Roche; Merck
Research Funding - alphamab (Inst); Astex Pharmaceuticals (Inst); British Biotech (Inst); CytomX Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Seagen (Inst); Taiho Pharmaceutical (Inst)
 
Erin V. Newton
No Relationships to Disclose
 
Ruth Oratz
No Relationships to Disclose
 
Marleen Iva Meyers
No Relationships to Disclose
 
Freya Ruth Schnabel
No Relationships to Disclose
 
Deborah M. Axelrod
No Relationships to Disclose
 
Kathie-Ann P. Joseph
No Relationships to Disclose
 
Karen Hiotis
No Relationships to Disclose
 
Andrea Troxel
No Relationships to Disclose
 
Sabrina McCoy
No Relationships to Disclose
 
Robert Schneider
No Relationships to Disclose
 
Sylvia Adams
Research Funding - Bristol-Myers Squibb (Inst); Merck (Inst)